Apelin/APJ system: a novel promising target for anti-oxidative stress in stroke

被引:0
|
作者
Xu, Weilin [1 ,2 ]
Yan, Jun [3 ]
Travis, Zachary D. [4 ]
Lenahan, Cameron [5 ]
Gao, Liansheng [1 ,2 ]
Wu, Haijian [1 ,2 ]
Zheng, Jingwei [1 ,2 ]
Zhang, Jianmin [1 ,2 ]
Shao, Anwen [1 ,2 ]
Yu, Jun [1 ,2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China
[2] Key Lab Precise Treatment & Clin Translat Res Neur, Hangzhou, Zhejiang, Peoples R China
[3] Guangxi Med Univ, Dept Neurosurg, Affiliated Tumor Hosp, Nanning, Peoples R China
[4] Western Univ Hlth Sci, Coll Hlth Sci, Dept Med Sci Educ, Pomona, CA USA
[5] New Mexico State Univ, Burrell Coll Osteopath Med, Las Cruces, NM USA
基金
中国国家自然科学基金;
关键词
apelin; APJ; stroke; oxidative stress; neuroprotection; ENDOPLASMIC-RETICULUM STRESS; VASCULAR SMOOTH-MUSCLE; ORPHAN RECEPTOR APJ; OXIDATIVE STRESS; ENDOGENOUS LIGAND; NITRIC-OXIDE; MESSENGER-RNA; DEPENDENT REGULATION; TISSUE DISTRIBUTION; SIGNALING PATHWAY;
D O I
10.3389/fphar.2024.1352927
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The apelin/APJ system has garnered increasing attention in recent years. In this review, we comprehensively discuss the physiological and pathological mechanisms of the apelin/APJ system in stroke. The apelin/APJ system is widely expressed in the central nervous system (CNS). However, the distribution of the apelin/APJ system varies across different regions and subcellular organelles of the brain. Additionally, the neuroprotective effects of the apelin/APJ system have been reported to inhibit oxidative and nitrative stresses via various signaling pathways. Despite this, the clinical application of the apelin/APJ system remains distant, as apelin has numerous active forms and signaling pathways. The development of a range of drugs targeting the apelin/APJ system holds promise for treating stroke.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Apelin/APJ system: A novel promising target for anti-aging intervention
    Zhou, Qionglin
    Chen, Linxi
    Tang, Mingzhu
    Guo, Yu
    Li, Lanfang
    CLINICA CHIMICA ACTA, 2018, 487 : 233 - 240
  • [2] Apelin/APJ system: A novel promising target for neurodegenerative diseases
    Luo, Huaiqing
    Han, Li
    Xu, Jin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (02) : 638 - 657
  • [3] Apelin/APJ system: A novel promising therapy target for pathological angiogenesis
    Wu, Lele
    Chen, Linxi
    Li, Lanfang
    CLINICA CHIMICA ACTA, 2017, 466 : 78 - 84
  • [4] Apelin/APJ system: a novel promising therapy target for thrombotic diseases
    Li, Lanfang
    Xu, Jin
    Chen, Linxi
    Jiang, Zhisheng
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (06) : 589 - 591
  • [5] Apelin/APJ system: a promising therapy target for hypertension
    Wu, Di
    He, Lu
    Chen, Linxi
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (10) : 6691 - 6703
  • [6] Apelin/APJ system: a promising therapy target for hypertension
    Di Wu
    Lu He
    Linxi Chen
    Molecular Biology Reports, 2014, 41 : 6691 - 6703
  • [7] The Protective Effects and Mechanisms of Apelin/APJ System on Ischemic Stroke: A Promising Therapeutic Target
    Tian, Yanjun
    Chen, Ruijiao
    Jiang, Yunlu
    Bai, Bo
    Yang, Tongju
    Liu, Haiqing
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [8] Apelin/APJ system: A novel therapeutic target for oxidative stress-related inflammatory diseases (Review)
    Zhou, Qun
    Cao, Jiangang
    Chen, Linxi
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 37 (05) : 1159 - 1169
  • [9] APJ/apelin: A promising target for the treatment of retinopathy of prematurity
    Su, Jingtian
    Zhang, Yixin
    Kumar, Senthil Arun
    Sun, Moran
    Yao, Yongfang
    Duan, Yongtao
    DRUG DISCOVERY TODAY, 2022, 27 (08) : 2342 - 2352
  • [10] Apelin/APJ system: A novel therapeutic target for locomotor system diseases
    Luo, Jingshun
    Liu, Wei
    Feng, Fen
    Chen, Linxi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 906